US Patent 8822511 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Patent 8822511 was granted and assigned to Incyte on September, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 28 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Andrew P. Combs0
Eddy W. Yue0
Richard B. Sparks0
Wenyu Zhu0
Edits on 21 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08822511 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase US Patent 8822511 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Infobox
Patent Number
088225110
Patent Number
88225110
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
088225110
Date of Patent
September 2, 2014
0Patent Application Number
140331170
Date Filed
September 20, 2013
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 24 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 08822511 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
08822511
Date of patent
September 2, 2014
Patent application number
14033117
Date Filed
September 20, 2013
Patent primary examiner
Find more entities like US Patent 8822511 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
